MedTech Collaborative: Hanover Monthly Meeting Registration

Transform Your Startup's Growth Journey

Opportunities for innovation are everywhere in healthcare, but not every great idea becomes a great business.

What separates the concepts that stay on the napkin from the ones that make it to market? Join us for a deep dive into the realities of building a startup — featuring founders who took clinical challenges from the whiteboard to commercialization.

Hosted by Simbex, a New Hampshire based medical device company that has been translating ideas into commercially viable solutions for over 20 years on a national scale, this event offers insights, lessons learned, and real-world strategies for navigating early-stage growth. Whether you're an aspiring founder, an industry professional, or just curious about the startup journey, this is your chance to connect, learn, and explore the path from concept to commercialization.

Ilsa Webeck

Director of Commercialization Services, Simbex

Ilsa leads the Commercialization Services team at Simbex, providing the commercial strategy and market intelligence support for MedTech innovators bringing new products to market. She brings an extensive marketing and product development experience to Simbex, working over 25 years at sector leading and international products companies. Taking both a broad perspective on the industry and a focused look at specific technology areas, she helps companies to uncover user needs and develop a clear product value proposition on the path to commercialization.

Richard Barth Jr., MD

Co-Founder, CMO, Cairn Surgical

Richard Barth Jr., MD, is a surgical oncologist with a focus on integrating new technologies for tumor resection and intraoperative margin delineation. His research, in collaboration with faculty at the Thayer School, has explored detection, diagnosis, therapy monitoring, and removal of breast cancer. He is particularly interested in intraoperative fluorescence for identifying surgical margins and is developing protocols for breast surgery. His work also investigates image-guided techniques to enhance resection completeness in breast lumpectomy. Access to intraoperative MRI will aid in validating cost-effective approaches and assessing intraoperative MR accuracy. As a mid-career mentor for COBRE junior faculty projects, he views the initiative as both a mentoring platform and an opportunity to advance his research. Previously, he served as principal investigator for an NCI-funded clinical trial using a dendritic cell vaccine for colorectal cancer metastatic to the liver and has contributed to multiple pancreatic cancer clinical trials.

Keith D. Paulsen, PhD

Co-Founder, Board Director & Chief Technology Officer, InSight Surgical Technologies

Dr. Paulsen, is InSight’s Co-founder, Board Director and Chief Technology Officer (CTO). Dr Paulsen is Professor of Biomedical Engineering, Radiology and Surgery at Dartmouth. He is an established NIH-funded investigator with substantial experience in biomedical research, leadership and administration. His research program has been and continues to be highly translational moving innovative technologies, many of which are developed in-house, into early-stage clinical studies. His positions include Director of the Advanced Imaging Center (AIC), which is an NIH-funded infrastructure program to promote and facilitate use of advanced imaging technologies in human and (large) animal subject research; Scientific Director of the Center for Surgical Innovation, also an NIH-funded infrastructure program to promote imaging and image guidance in the setting of surgical intervention; and Co-Director of the Translational Engineering in Cancer Research Program of the NCI-designated Norris Cotton Cancer Center. Dr. Paulsen is a Co-Founer of CairnSurgical, Inc. He is inventor on 40+ patents/patents-pending and teaches courses in medical device development and surgical innovation.

Paresh Shah

President & Founder, CliniLink

Paresh Shah began his healthcare career in Health-IT, implementing a Mumps-based Radiology Information System in 1989. With decades of experience guiding healthcare professionals in federal and government institutions through compliance and Health-IT challenges, he now leads CliniLink Health, a spin-off from Mindleaf Technologies, Inc.

Aravindhan Sriharan

Founder, PixCell

Today, every cancer patient - and hundreds of other diseases - are diagnosed by a pathologist looking at their tissue under the microscope. Widespread digital pathology would give patients human supervised, AI-guided diagnostics, while addressing the shortage of pathologists in the US and abroad. The PixCell SmartScope is a device that facilitates widespread digital pathology.